← Back to Search

Procedure

Sternal Closure Techniques for Heart Disease

N/A
Waitlist Available
Led By Rakesh Arora, MD
Research Sponsored by Marc Pelletier
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BITA grafting
Undergoing cardiac surgery through sternotomy with ≥2 risk factors: Diabetes mellitus, Severe COPD, Chronic steroid use, Immunosuppression, Redo sternotomy, Chronic kidney disease with GFR >30 ml/min per 1.73m2, Radiation therapy, BMI≥35, High-risk of delirium, Heavy alcohol use
Must not have
Active malignancy
NYHA Class IV
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking for volunteers who have heart disease and are scheduled for open heart surgery. The study will compare two techniques used to close the sternum after surgery. Participants must be over 18 and

Who is the study for?
This trial is for adults over 18 with heart disease who are scheduled for open-heart surgery and at high risk of sternal wound complications. Specific eligibility details were not provided, so interested individuals should inquire further about inclusion and exclusion criteria.
What is being tested?
The study compares two methods of closing the sternum after open-heart surgery: Rigid Sternal Fixation using a Sternal Plate versus Wire Cerclage. The goal is to evaluate which technique better prevents sternal wound complications.
What are the potential side effects?
Potential side effects may include issues related to the surgical site such as pain, infection, or poor healing at the bone where the chest was opened. However, specific side effects associated with each method have not been detailed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had or will have BITA grafting.
Select...
I am having heart surgery and have two or more specific health issues.
Select...
My chest was opened in a way that did not split my breastbone down the middle.
Select...
I have a broken breastbone.
Select...
My heart-lung machine use was 2 hours or more.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I currently have cancer.
Select...
My heart condition severely limits my physical activity.
Select...
My chest surgery was not through the standard midline cut.
Select...
I had heart surgery with a very narrow chest bone cut.
Select...
I am currently experiencing bleeding.
Select...
I have had complications from surgery.
Select...
My kidney function is severely reduced.
Select...
I need urgent or rescue surgery.
Select...
My chest was not closed immediately after heart surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of sternal wound complications as measured by patient/physician report
Sternal healing as measured by CT scan
Total cost
+1 more
Secondary study objectives
Change in pain as measured by the Wong-Baker pain scale
Change in prescribed narcotic use as measured by patient report
Change in quality of life as measured by the EuroQol EQ-5D-5L
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Rigid Sternal FixationExperimental Treatment1 Intervention
The surgeon will close the sternum (breastbone) using the SternalPlate system. The SternalPlate System consists of implants and instruments used to hold the two halves of the sternum together.
Group II: Wire CerclageActive Control1 Intervention
The surgeon will close the sternum (breastbone) using Wire Cerclage. Wire Cerclage consists of stainless steel wires used to hold the two halves of the sternum together.

Find a Location

Who is running the clinical trial?

Marc PelletierLead Sponsor
2 Previous Clinical Trials
34 Total Patients Enrolled
Stryker NordicIndustry Sponsor
34 Previous Clinical Trials
4,149 Total Patients Enrolled
Rakesh Arora, MDPrincipal InvestigatorUniversity Hospitals
2 Previous Clinical Trials
112 Total Patients Enrolled
Marc Pelletier, MDPrincipal InvestigatorUniversity Hospitals
2 Previous Clinical Trials
34 Total Patients Enrolled
~167 spots leftby Jun 2027